In analyses of only those patients with adenocarcinoma, the median CEA level was 5.2 ng/mL in the ALK group and 17.3 ng/mL in the EGFR group, with a statistically significant difference (p = 0.007). The gene discussed is CEACAM5; the disease is adenocarcinoma.